Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation
Clinical trial NCT03989089 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03989089
- Sponsor
- University of Malaya
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-03
- Primary completion
- 2025-12-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.